![]() |
|
|
Vol. 287, Issue 2, 480-486, November 1998
Research Department, Novartis Pharmaceuticals Corp., Summit, New Jersey
| |
Abstract |
|---|
|
|
|---|
In light of recent reports linking K+ channel modulation with food intake and macronutrient preference, we investigated the effect of anorectic agent dexfenfluramine (d-FF), a 5-HT reuptake inhibitor and releasing agent, on the delayed rectifier K+ (DRK) channels in rat lingual taste cells using the patch-clamp technique in whole-cell configuration. In a concentration-dependent manner, d-FF caused a reduction of the DRK currents in taste cells with an IC50 of 30.5 µM. Other anorectics that promote 5-HT activity such as fenfluramine, sibutramine and m-chlorophenylpiperazine (a specific 5-HT2C receptor agonist) produced inhibition of DRK currents of a similar pattern with a respective IC50 of 69.0, 8.6 and 95.4 µM. The actions of all compounds had rapid onset and were readily reversible. The inhibitory effects were not secondary to their stimulation of 5-HT, because direct application of 5-HT up to 1 mM did not alter DRK current. In addition, d-FF-induced current reduction was not prevented by either the 5-HT synthesis inhibitor p-chlorophenylalanine or 5-HT receptor antagonist metergoline. d-FF was also tested in cardiac ventricular myocytes that are reportedly abundant in DRK channels and was found to depress the DRK currents concentration-dependently with an IC50 of 250.9 µM. These results indicate an important pharmacological role for d-FF as an inhibitor of the DRK channels. The common inhibitory effect on DRK channels in oral taste cells and cardiac cells by this class of compounds might contribute to the anorectic and some of the detrimental cardiovascular effect associated with long-term exposure.
| |
Introduction |
|---|
|
|
|---|
The
anorectic agent dextenfluramine (d-FF), known as Redux, is a serotonin
reuptake inhibitor and releasing agent. The importance of serotonin in
the control of eating behavior and the mediation of satiety has long
been established (Blundell, 1977
, 1984
; Leibowitz and Shor-Posner,
1986
). It was believed that procedures that increase hypothalamic
extracellular 5-HT availability or 5-HT receptor activation reduce food
consumption, whereas procedures that reduce serotonin activity bring
about the opposite effect. However, much of the recently accumulated
data were not consistent with d-FF and other related appetite
suppressants acting by boosting 5-HT activity, because the anorectic
activity was not blocker by either the 5-HT neurotoxin (Grignaschi and
Samanin, 1992
) or by 5-HT synthesis inhibitor (Caccia et
al., 1992
; Gibson et al., 1993
; Oluyomi et
al., 1994
; Lightowler et al., 1996
). These discordant findings suggest the existence of possible additional mechanism(s) underlying the anorectic effect of these agents.
It has been recently reported that centrally acting
K+ channel modulators play a regulatory role in
food intake in rats (Ghelardini et al., 1997
). The study
demonstrated that intracerebroventricular administration of
K+ channel antagonists produced a decrease in
food consumption and the opposite was true with
K+ channel agonists. The K+
channel activity in peripheral cells was reported to be associated with
macronutrient preference (Liu et al., 1997
). Specifically, the delayed rectifier K+ (DRK) channels in rat lingual
taste cells was found to be inhibited by polyunsaturated fatty acids,
and the degree of susceptibility to fatty acids was inversely
correlated with fat preference in rats. Consistent with the potential
regulatory role of K+ channels in feeding
behavior, weight gain has been reported in humans in the clinical trial
of orally administered pinacidil, a known K+
channel opener (Friedel and Brogden, 1990
). Collectively, these results
suggested an active role for K+ channel
modulation in the determination of food preference and consumption.
The present study, using the patch-clamp technique, was designed to
evaluate the response of the voltage-gated DRK channels in taste cells
from fungiform papillae of rat tongues to a number of anorectic agents.
Test substances were either 5-HT reuptake inhibitors and releasing
agents like d-FF, fenfluramine (FF) and sibutramine (SB) or
5-HT2C receptor agonist like
m-chlorophenylpiperazine (mCPP). The latter was chosen
because d-FF appeared to exert an anorectic effect by directly acting
on 5-HT2C receptor (Gibson et al.,
1993
). Given that the DRK current in taste cells demonstrates physiological and pharmacological characteristics typical of the DRK
current in cardiac myocytes, the effect of d-FF was also examined in
rat ventricular myocytes. The results revealed a common inhibitory effect on DRK currents from these two distinct types of cells. We
propose that the effect may be a contributing mechanism to the
beneficial anorectic as well as the recently documented adverse cardiaovascular actions of d-FF.
| |
Methods and Materials |
|---|
|
|
|---|
Isolation of rat taste buds.
Individual taste buds were
isolated from the tongues of Sprague-Dawley rats (250 to 300 g)
with the procedure described earlier (Bene et al., 1990
).
The rats were killed by CO2 inhalation. The tongues were cut at the extreme posterior region where vallate papillae
are located and immediately placed in ice-cold Tyrode's solution. To
remove the lingual epithelium in which the taste buds embedded from the
underlying muscle layer, Tyrode's solution containing 0.5 mg/ml
collagenase A (Boehringer-Mannheim), 5 mg/ml dispase (grade II,
Boehringer-Mannheim) and 1 mg/ml trypsin inhibitor (type I-S, Sigma)
was injected subcutaneously into the ventral and dorsal sides of the
fungiform papillae and around the vallate and foliate papillae. The
injected tongue was incubated in oxygen bubbled
Ca++- and Mg++-free
Tyrode's for 35 min. The epithelium around the papillae was gently
lifted away from the rest of the tongue, and pinned serosal side up in
Ca++- and Mg++- free
Tyrode's. In most cases, a complementary 20 min incubation at room
temperature was necessary to loosen the tight junction and therefore
the attachment of the buds to the papillae. A glass capillary with a
firepolished tip opening of ~200 µm was introduced into the
papillae and the taste buds were individually sucked into the capillary
and then transferred to a recording chamber filled with Tyrode's solution.
Isolation of rat cardiac ventricular myocytes.
Sprague-Dawley rats (250 to 300 g) rats were killed by i.p.
injection of 1 ml of Na pentobarbital at 60 mg/ml. The chest was opened, and the heart was quickly excised and immersed in prewarmed (to
34°C) and preoxygenated Tyrode's solution. The left ventricle was
dissected and cut into small strips. The muscle strips were then
incubated in continuously oxygenated Tyrode's solution containing 2 mg/ml collagenase (type I, Sigma) and 4 mg/ml bovine albumin (fraction
V, GIBCO) at 34°C for 1 hr. At the end of incubation, the enzyme
solution was removed and muscle strips were rinsed with "KB"
solution (Isenberg and Clockner, 1982
) for several times. The muscle
pieces were placed in a test tube half-filled with KB solution, and
single ventricular myocytes were released by gently shaking the test tube.
Electrophysiological recording.
K+
currents were recorded in rat taste receptor cells maintained in the
taste buds or in single ventricular myocytes by using the whole-cell
configuration of the patch-clamp technique (Hamill et al.,
1981
). The recording chamber consisted of a Corning 35 mm culture dish
fitted with a Sylgard O-ring of ~3 mm thickness and ~10 mm inner
diameter residing on top of a Corning 22-mm2
cover glass, resulting in a chamber volume of ~0.3 ml. Taste buds,
viewed with Nikon inverted microscope at a magnification of 600×, were
attached to the cover glass after a typical 10-min settling time. The
experimental chamber was continuously superfused with Tyrode's
solution with and without testing drugs at a constant rate of ~1.5
ml/min. The perfusion system was built such that the test solutions
would reach the chamber in <15 sec, once the microswitch was turned
on. As a standard procedure, recordings were always made at 1 min after
the perfusion, which was taken as time zero in all electrophysiological
studies. According to the perfusion rate and the volume of the chamber,
a time period of 1 min would allow a complete replacement of the
previous solution by the new solution. Patch electrodes were pulled
from Kimax-51 capillary tubes (Kimble Products, NJ). The resistance of
electrodes after firepolishing was around 5 M
for taste receptor
cells and 2 M
for cardiac cells. The junction potential between the
electrodes and the bath solution was compensated using the DC offset in
the amplifier. Series resistance were typically in the range between 3 and 6 M
, of which 70% was electronically compensated. No leak subtraction was applied.
80 and
+80 mV with an increment of 20 mV from a holding potential of
80 mV.
The currents were amplified by a List EPC-7 amplifier (Adams & List
Assoc., Darmstadt, Germany), digitized at 4 kHz with a TL-1-125 DMA
interface (Axon Instruments, Burlingame, CA) and stored on a personal
computer. Data were analyzed with pClamp software version 6.03. All
experiments were performed at room temperature ~22°C.
The amplitude of the DRK currents elicited by depolarizing voltage step
to +60 mV was used as an index to construct concentration-response relationship, in which the remaining currents in the presence of drugs,
expressed as a percent of the currents in the control, were plotted
against drug concentrations. The points were fit to the logistic
equation with a general nonlinear, least-square analysis using the
Gauss-Newton algorithm as modified by Marquardt and Levenburg (Fletcher
and Shrager, 1973Solutions.
Tyrode's solution, also used as bath solution,
contains (in mM) 140 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose and 10 Na pyruvate,
pH 7.4. In Ca++- and
Mg++-free Tyrode, nominally zero
CaCl2 and MgCl2 was
supplemented with 2 mM BAPTA (Sigma). The intracellular pipette
solution is composed of (in mM) 140 KCl, 0.1 CaCl2, 2 MgCl2, 0.6 EGTA, 3 K2ATP, 2 Na2UDP and 10 HEPES, in which the free Ca++ concentration was
estimated to be 10
8 M (Imai and Takeda,
1967
). The "KB" solution contains (in mM) 85 KCl, 30 K2HPO4, 5 MgSO4, 5 Na2ATP, 5 pyruvic
acid, 5 creatine, 20 taurine, 5 DL-
-OH butyric acid and
1g/l bovine albumin.
Materials. Collagenase A and dispase were purchased from Boehringer-Mannheim (Indianapolis, IN) and bovine serum albumin was from GIBCO (Gaithersburg, MD). Fenfluramine, serotonin, trypsin inhibitor (type I-S) and all salts were obtained from Sigma (St. Louis, MO). Dexfenfluramine and sibutramine were synthesized in the Research department at Novartis Pharmaceuticals Corp. All drugs, being water soluble, were directly dissolved in Tyrode's solution to form a stock solutions of 50 mM in concentration and then diluted with Tyrode's to the desired concentrations for testing.
| |
Results |
|---|
|
|
|---|
The whole-cell outward K+ currents in taste
cells were elicited by a series of voltage steps varying between
80
and +80 mV with an increment of 20 mV from a holding potential of
80
mV. The currents were voltage dependent, fast activating and slowly inactivating. We found that the currents were insensitive to
dendrotoxin (up to 1 mM), iberiotoxin (up to 100 nM), charybdotoxin (up
to 200 nM), apamin (up to 1 mM) and glyburide (up to 5 mM) but were inhibited by TEA, 4-AP, quinine, nifedipine, terfenadine and flecainine in a concentration-dependent manner (fig.
1). The concentrations for a half-maximal
inhibition (IC50) of the K+
currents elicited by a +60 mV depolarizing step were, respectively, 2.0 mM, 4.7 mM, 9.0 µM, 16.8 µM, 3.9 µM and 29.3 µM for the
aforementioned K+ channel blockers (fig. 1). The
electrophysiological and pharmacological properties of the
K+ currents in taste cells were consistent with
those of the voltage-dependent DRK channels (Hume, 1985
; Bokvist
et al., 1990
; Dreyer, 1990
; Lu et al., 1990
;
Rampe et al., 1993
; Daleau et al., 1997
) but not
the Ca++-activated and ATP-sensitive
K+ channels, although the latter channels have
been identified in taste cells (Fujiyama et al., 1994
;
Lindemann, 1996
).
|
Typical responses to d-FF of the DRK currents in a taste cell are shown in figure 2A, in which the drug reduced the current amplitude in a concentration-dependent manner. The action had a rapid onset and recovery. Specifically, the response was observed typically within 1 min of d-FF application and reached a steady state in ~4 min. Reversal of the blockade upon removal of d-FF was completed between 4 and 5 min. The inhibitory effect is also reflected in the current-voltage relationship (fig. 2B), in which the blockade appears to be weakly voltage dependent, with more blockade at higher depolarized potentials.
|
Parallel studies were undertaken with the anorectic agents FF, SB and
mCPP. These drugs caused an inhibitory effect on DRK currents in a
manner that was strikingly similar to that induced by d-FF. Figure
3 displays superimposed records of the
DRK current at +60 mV without and with FF at concentrations indicated
in the figure. The results with SB are shown in figure
4, A and B, in which the
concentration-dependent inhibition of DRK currents was readily visible.
SB seemed relatively more potent than d-FF with a minimal effective
concentration of 0.3 µM. As d-FF reportedly exerts the anorectic
effect by directly acting on 5-HT2C receptor (Gibson et al., 1993
), mCPP, a selective
5-HT2C receptor agonist, was also found to
reversibly block the DRK currents in taste cells (data not shown).
|
|
To determine whether d-FF, FF, SB and mCPP acted directly on the channel gating to block the DRK channels or acted indirectly through a 5-HT mediated mechanism to affected the channels, 5-HT between concentrations of 1 µM and 1 mM was directly applied to the taste cells and failed to significantly alter the DRK currents. In addition, the 5-HT synthesis inhibitor p-chlorophenylalanine (PCPA) up to 1 mM neither altered DRK currents (fig. 5B) nor blocked d-FF-induced inhibitory effect (fig. 5C). These results suggest that the blocking effect on DRK channels was independent of 5-HT availability. Another result argued against the involvement of 5-HT activation in the blockade of DRK currents is shown in figure 6, in which metergoline (MTG), a nonselective 5-HT receptor antagonist, acted as an agonist in reducing DRK currents (fig. 6B) with IC50 of ~10 µM (results not shown). At submaximal concentrations its effect was additive to that of d-FF, a result implying an involvement of the 5-HT receptor in the blockade of DRK channels.
|
|
Using the amplitude of DRK currents at +60 mV as an index,
concentration-response curves for all drugs tested were constructed (fig. 7). The IC50
values obtained from the least square fitting of the data (Fletcher and
Shrager, 1973
) were 8.6, 30.5, 69.0 and 95.4 µM, respectively, for
SB, d-FF, FF and mCPP.
|
Cardiac myocytes are rich in DRK channels and these channels constitute
the major component of outward K+ current and
participate in mediating repolarization of action potential (Noble,
1984
). We found that d-FF caused a reversible and
concentration-dependent inhibition of the DRK currents in cardiac
myocytes (fig. 8A). The effect is also
illustrated in the current-voltage relationship in figure 8B and in the
concentration-response curve in figure 8C. A least-squares fitting with
the percent inhibition of the current at +60 mV resulted an
IC50 of 250.9 µM, ~8 times that in the taste
cells.
|
| |
Discussion |
|---|
|
|
|---|
d-FF, FF and SB have been established as centrally acting
anorectic agents, whose mechanism of action is believed to be
attributed to their ability to stimulate the activity of 5-HT. Such a
traditional concept has been challenged by increasing number of recent
publications, which directly contradicted a 5-HT mediated mechanism,
because the anorectic activity was not blocker by either the 5-HT
neurotoxin (Grignaschi and Samanin, 1992
) or by 5-HT synthesis
inhibitor (Caccia et al., 1992
; Gibson et al.,
1993
; Oluyomi et al., 1994
; Lightowler et al.,
1996
). Thus, additional mechanism(s), central and/or peripheral, may
exist to contribute to the control of appetite by this class of
compounds. We speculated a role of K+ channels
underlying the action of these anorectics in the light of the recent
reports revealing a regulatory effect of centrally acting
K+ channel modulators on food consumption
(Ghelardini et al., 1997
) and a linkage between the
macronutrient preference and K+ channel
expression in taste cells (Liu et al., 1997
). The results of
the present study, for the first time, provided evidence that 5-HT
boosting anorectics suppressed DRK channels in lingual taste cells. In
addition to the well established concept that the DRK channels in taste
cells play a pivotal role in the gustatory transduction of basic tastes
like sour, bitter and sweet (Avenet and Kinnamon, 1991
; Kinnamon, 1992
;
Gilbertson, 1993
), a recent study indicated that the same DRK channels
in taste cells may be involved in chemoreception of dietary fat through
their direct inhibition by essential fatty acids (Gilbertson et
al., 1997
). The blockade of DRK channels would be predicted to
promote action potential firing leading to neurotransmitter release to
gustatory afferent nerves. This sequence of events may contribute to
the suppression of fat preference through enhancement of the satiating
power of dietary fats (Smith et al., 1998
). Given the
reduction of food consumption by centrally acting
K+ channel blockers (Ghelardini et
al., 1997
), our finding of the inhibitory effect of 5-HT agonists
on the DRK channels in taste cells may suggest a peripheral route by
which these drug produce anorectic action.
The inability of 5-HT to block the DRK currents in taste cells, in
combination with the observation that the inhibitory effect by d-FF was
not affected by PCPA (a 5-HT synthesis inhibitor), suggests that the
d-FF-induced-blocking effect was independent of 5-HT availability. On
the other hand, MTG, a nonselective 5-HT receptor antagonist, inhibited
DRK channels, and its effect was additive to that of d-FF at submaximal
concentrations, a result implying an involvement of the 5-HT receptor
in d-FF effect. To explore whether alteration of 5-HT receptor activity
is responsible for the effect of d-FF on DRK current, we compared the
effect when the taste cells were dialyzed with G protein inhibitor,
GDP
S, with that in control, because 5-HT receptors belong to the
superfamily of G protein-coupled receptors. The results convincingly
showed that the blockade of G protein by GDP
S did not at all affect the concentration dependence and the time course of the d-FF effect on
the K+ current (data not shown). These
observations tended to argue against the involvement of G protein and
intracellular signaling pathways. Although the coupling between the
5-HT receptor and the DRK channel in response to d-FF and other
anorectics has yet to be delineated, our results suggest that these
5-HT boosting agents blocked DRK channels by a mechanism requiring 5-HT
receptors but not 5-HT stores. Interestingly, our findings coincide
with the reported observation that the anorectic effect of d-FF depends only on the 5-HT receptor but not 5-HT availability (Curzon et al., 1997
).
As all anorectics tested were hydrophilic in nature and were applied extracellularly, the rapid onset and washout of the blocking effects on the channels led us to propose a direct action at a site located on or close to the external surface of the cell membrane. To validate the hypothesis, we attempted to record the effect of intracellularly applied d-FF on the single DRK channel activity from inside-out detached membrane patches of taste cells. The time and concentration dependence of the effect could be indicative of the location of the site of action in reference to cell membrane and of the possible involvement of cellular second messenger(s), because in excised membrane patches the intracellular biochemical and biophysical pathways are usually disrupted due to lack of substrates and cellular organelles. However, we were unable to isolate and quantitatively analyze the activity of DRK channel under the influence of the anorectics due to the complexity of coexistence of multiple channels types with varying single-channel conductances in taste cell membrane.
As the knowledge of the molecular structure of the
K+ channels that contribute to the DRK currents
in taste cells is vitally important in determining the selectivity of
these 5-HT boosting anorectics, we recently conducted studies to
identify the subtype of the DRK channels in taste cells using multiple
molecular biology and immunology tools. Preliminary results showed that
a Shaker Kv1.5-like channel constituted the major component, whereas a Shab Kv2.1 channel was likely a minor component of the total DRK current in taste cells (Liu et al., 1998
).
Cardiac myocytes possess DRK channels, and these channels are the major
contributors to the outward K+ current mediating
repolarization of action potential (Noble, 1984
). Modern molecular
cloning has revealed the primary structure of the cardiac DRK channels,
of which Kv1.5 channel represents a prominent component (Roberds
et al., 1993
). The inhibition of DRK current in cardiac
myocytes by d-FF, albeit at higher concentration than that in taste
cells, could inherently lead to the delay of repolarization and hence
the prolongation of action potential duration accompanied by positive
inotropy in the heart (Tande and Refsum, 1998
). In the long run, the
sustained prolongation of repolarization and elevation of contractility
of cardiac tissues could lead to Ca++ overload
and energy exhaustion. Chronic administration of d-FF reportedly causes
pulmonary hypertension associated with increase in right ventricular
systolic pressure and pulmonary arterial pressure (Abenhaim et
al., 1996
; SoRelle, 1997
; Connolly et al., 1997
). While
the latter effect appears to be in part mediated by its inhibition of
K+ channels in pulmonary vascular smooth muscle
cells (Weir et al., 1996
; Curfman, 1997
), the blockade of
cardiac DRK channels may contribute to the elevation of right
ventricular pressure. It remains to be determined whether the cardiac
effects resulting from the blockade of DRK channels would contribute to
the pathogenesis of the clinical observation of regurgitant valvular
heart disease developed after long-term treatment of d-FF (Graham and
Green, 1997
;. Cannistra et al., 1997
), which has been
suggested to be related to alterations in the concentration of
circulating serotonin (Connolly et al., 1997
).
In conclusion, our results indicate an important pharmacological role
for d-FF and other 5-HT boosting agents as blockers of DRK channels
via mechanism(s) that are independent of 5-HT availability.
Although the effect in taste cells may contribute to anorectic action,
the ubiquity of DRK channels in cardiac, neuronal, skeletal and smooth
muscle cells (Rudy, 1988
) could imply more extensive activities
produced by this class of agents in the body.
| |
Footnotes |
|---|
Accepted for publication June 18, 1998.
Received for publication March 17, 1998.
1 Present address: Louisiana State University, Baton Rouge, LA 70808.
Send reprint requests to: Dr. Shiling Hu, Research Department, Novartis Pharmaceuticals Corp., 556 Morris Avenue, Summit, NJ 07901. E-mail: shiling.hu{at}pharma.novartis.com
| |
Abbreviations |
|---|
d-FF, dexfenfluramine; FF, fenfluramine; SB, sibutramine; mCPP, m-chlorophenylpiperazine; PCPA, p-chlorophenylalanine; MTG, metergoline; DRK, delayed rectifier K+.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. E. Kim, H. S. Ahn, B. H. Choi, H.-J. Jang, M.-J. Kim, D.-J. Rhie, S.-H. Yoon, Y.-H. Jo, M.-S. Kim, K.-W. Sung, et al. Open Channel Block of A-Type, Kv4.3, and Delayed Rectifier K+ Channels, Kv1.3 and Kv3.1, by Sibutramine J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 753 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. McDaniel, O. Platoshyn, Y. Yu, M. Sweeney, V. A. Miriel, V. A. Golovina, S. Krick, B. R. Lapp, J.-Y. Wang, and J. X.-J. Yuan Anorexic effect of K+ channel blockade in mesenteric arterial smooth muscle and intestinal epithelial cells J Appl Physiol, November 1, 2001; 91(5): 2322 - 2333. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Michelakis, E. K. Weir, D. P. Nelson, H. L. Reeve, S. Tolarova, and S. L. Archer Dexfenfluramine Elevates Systemic Blood Pressure by Inhibiting Potassium Currents in Vascular Smooth Muscle Cells J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1143 - 1149. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||